Floretina ICOOR 2024
rtx1 AO retinal camera
The extraordinary resolution of adaptive optics (AO) with a device designed for clinical settings. Extensively validated by 250+ publications, rtx1 reveals microscopic lesions and minute progressions through quick exams. It provides quantitative biomarkers of photoreceptor cells, RPE and microvascular alterations. Moreover, new features streamline AO examinations for multicentric clinical studies and trials.
For the first time, the rtx1 device comes to Floretina: we will be happy to introduce its current capabilities with live demos.
For trial sponsors and CROs
We offer global services for a successful implementation of AO biomarkers in studies and trials, thanks to our partner Emsere. Schedule a meeting at Floretina to discuss how to accelerate your developments of retinal therapies.
New in AO imaging in 2024
We showcase the rtx1 AO retinal camera with exciting new features that streamline its implementation in clinical studies and trials, and extends investigations to new candidate biomarkers.